Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER Pharmacogenetics and Efficacy in Schizophrenia
NCT02433717Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paliperidone in schizophrenia, schizoaffective disorder, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
paliperidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT02433717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02433717.